300147 Stock Overview
Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Xiangxue Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.62 |
| 52 Week High | CN¥16.49 |
| 52 Week Low | CN¥3.00 |
| Beta | 0.52 |
| 11 Month Change | 27.22% |
| 3 Month Change | 84.50% |
| 1 Year Change | 114.63% |
| 33 Year Change | 91.50% |
| 5 Year Change | 95.05% |
| Change since IPO | -10.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300147 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 6.9% | -1.5% | -2.1% |
| 1Y | 114.6% | -9.4% | 2.8% |
Return vs Industry: 300147 exceeded the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 300147 exceeded the CN Market which returned 2.8% over the past year.
Price Volatility
| 300147 volatility | |
|---|---|
| 300147 Average Weekly Movement | 17.7% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300147's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300147's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 2,644 | Yonghui Wang | www.xphcn.com |
Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd.
Xiangxue Pharmaceutical Co.,Ltd. Fundamentals Summary
| 300147 fundamental statistics | |
|---|---|
| Market cap | CN¥8.35b |
| Earnings (TTM) | -CN¥460.69m |
| Revenue (TTM) | CN¥2.10b |
4.0x
P/S Ratio-18.1x
P/E RatioIs 300147 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300147 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.10b |
| Cost of Revenue | CN¥1.51b |
| Gross Profit | CN¥595.99m |
| Other Expenses | CN¥1.06b |
| Earnings | -CN¥460.69m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.70 |
| Gross Margin | 28.32% |
| Net Profit Margin | -21.89% |
| Debt/Equity Ratio | 108.6% |
How did 300147 perform over the long term?
See historical performance and comparison